For professionals
Memory Clinic
At ReMind UK we welcome both NHS and private referrals to our memory clinic. Patients are usually referred by their GP with a suspicion of memory problems. GPs are asked to complete the following tests before referral to ReMind UK:
- ReMind UK require recent full blood count, renal and liver function, calcium, glucose and cholesterol test, and that thyroid function, B12 and folate levels are normal before referral.
- For BANES GP’s use the ReMind UK blood profile on ICE.
- We also require a CT head scan.
Resources for professionals:
Tell your patients about our new Guide to Living Well with Dementia. A collection of advice, tips and signposting to services in BANES. Created by our psychological support team with patients and their carers in mind.
Print out one of ReMind UK’s leaflets for your patients to take away with them and read.
Dementia research
ReMind UK actively explores all aspects of ageing well, including how we might use drug treatments more safely in older people. A major focus of our clinical research is exploring the way in which people respond to treatments when they get older, including when dementia such as Alzheimer’s disease develops. Our purpose-built research centre, located at The Royal United Hospital (RUH) site in Bath, has facilities for clinical studies, and is particularly well suited for clinical trials exploring new drug treatments for dementia and memory decline. The ReMind UK centre is fully equipped for pharmacokinetic studies and has an experienced team of medical, nursing, psychology and research staff.
Current dementia research studies open for patient referrals:
Please get in touch with ReMind UK in order to refer a patient for any of the dementia research or Alzheimer’s disease clinical trials listed below. We are actively recruiting for these studies.
This study, run by the University of Oxford, is looking for participants aged 45 years and older who have either been diagnosed with dementia or Mild Cognitive Impairment or have presented to a clinician with memory complaints but have no specific diagnosis. You will be invited to the ReMind UK Clinic to give a single blood sample of 20 mL (roughly the same as 1.5 tablespoons), answer some questions about your medical history and demographics and complete a questionnaire about your feelings toward dementia diagnosis and whether blood tests may be a useful tool for your medical care.
Eligibility requirements:
- Dementia (all sub-types), MCI or have presented to a clinician with memory complaints without a specific diagnosis
- Aged 45+
Merck MK-1167
Testing a capsule taken orally for treatment of mild to moderate Alzheimer’s disease.
Eligibility requirements:
- Mild to moderate Alzheimer’s disease
- Aged 55-90
- MMSE (Mini-Mental State Examination) score of 12-24
- Able to undergo an MRI or CT scan
CareCoach is an online support package which focuses on helping caregivers develop knowledge, skills, and confidence to manage and support the care they provide a person living with dementia. Care givers using CareCoach are also supported and guided by a ‘coach’ (health, social care or dementia charity worker).
Eligibility requirements:
- Currently providing unpaid care/support to someone living with any subtype of dementia, diagnosed in the past 5 years
- Aged 18+
- Access to the internet
The ReTain clinical research study is for adults who are concerned about their risk of developing Alzheimer’s disease. Participants must be currently healthy with no cognitive impairment. The trial will assess the effect of an immunotherapy medication on cognitive decline, this medication will be given by injection to the arm.
Eligibility requirements:
- No diagnosis (preclinical AD)
- Age 55-75
- MMSE (Mini-Mental State Examination) score of 27 and over
- Able to undergo MRI and PET scans
Phase 3 research trial to assess the safety and efficacy of donanemab infusions in participants with early Alzheimer’s disease.
Eligibility requirements:
- 60-85 years old
- Diagnosis of Mild Cognitive Impairment, or Mild Alzheimer’s disease, or no diagnosis but gradual/progressive memory changes for 6 months or more.
- MMSE (Mini-Mental State Examination) score of 20-28 inclusive.
- Able to undergo MRI and PET scans.
The Fastball study involves showing a person some pictures to remember and then showing the pictures to them at a very fast rate, mixed up amongst pictures they have not seen. Using Electroencephalography (EEG), which measures brain activity using easy-to-use headsets, it’s possible to see brain waves from areas of the brain that recognise images, to show whether the person remembers the pictures or not. The Research Team – led by the Department of Psychology at the University of Bath, in partnership with the University of Bristol, University College London (UCL), Cumulus Neuroscience Ltd., and the North Bristol NHS Trust – has already shown that Fastball can detect the early stages of dementia, and it works whatever language the person speaks, how educated or nervous they are. Fastball is now being used in dementia clinics in Bristol and Bath to see if dementia can be diagnosed earlier and more accurately than with pen and paper tests.
Eligibility requirements:
- Aged 55+
- Participants must be willing to have an EEG testing session either at home or the University of Bath.
Exclusion criteria:
- You have a neurological disorder
- You have a known history of epilepsy or seizures
- You have ever experienced discomfort or adverse reactions to flickering visual/light stimuli
- You have experienced any unexplained episodes of feeling faint and/or confused
- You have a history of epilepsy in your family